Related Experiment Video

Updated: Aug 23, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by

Keira L Watts1, Monica A Spiteri

  • 1Lung Research, Institute of Science and Technology in Medicine, University Hospital of North Staffordshire/Keele University, Stoke on Trent, United Kingdom. keira_watts@yahoo.co.uk

American Journal of Physiology. Lung Cellular and Molecular Physiology
|August 10, 2004
PubMed

Insights

Simvastatin reduces connective tissue growth factor (CTGF) in lung fibroblasts by inhibiting cholesterol synthesis and involving Rho signaling, offering potential for fibrotic disease therapies.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Pulmonary Medicine

Background:

  • Connective tissue growth factor (CTGF) is a key mediator of fibrosis, driving fibroblast proliferation and extracellular matrix deposition.
  • Idiopathic pulmonary fibrosis (IPF) involves CTGF upregulation, yet effective therapies are lacking.
  • Simvastatin has shown potential antifibrotic effects in renal fibroblasts.

Purpose of the Study:

  • To investigate the antifibrotic actions of simvastatin on human IPF-derived and normal lung fibroblasts.
  • To elucidate the mechanisms underlying simvastatin's effects on CTGF and transforming growth factor-beta (TGF-beta) interactions.

Main Methods:

  • Assessed simvastatin's impact on basal and TGF-beta-induced CTGF gene and protein expression.
  • Utilized transient reporter transfection with a CTGF promoter construct to evaluate signaling pathways.
  • Investigated the role of geranylgeranylpyrophosphate (GGPP) and small GTPases (Rho, Ras) in simvastatin's effects.
  • Employed Rho-specific inhibitors and RhoA constructs to confirm signaling involvement.

Main Results:

  • Simvastatin reduced basal CTGF expression and inhibited TGF-beta-induced CTGF promoter activity in a dose-dependent manner.
  • Simvastatin's effects were linked to cholesterol synthesis inhibition and involved Rho signaling, not Ras.
  • GGPP, but not farnesylpyrophosphate, restored CTGF promoter activity after simvastatin treatment.
  • Rho inhibition significantly suppressed TGF-beta-induced CTGF promoter activity.

Conclusions:

  • Simvastatin modulates CTGF expression and its interaction with TGF-beta in lung fibroblasts via a cholesterol synthesis-dependent Rho signaling pathway.
  • These findings suggest simvastatin as a potential therapeutic agent for fibrotic lung diseases by targeting CTGF-driven mechanisms.

More Related Videos

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...